Susi Roger E., CEO, President, and Chairman of iRadimed Corporation (IRMD), has demonstrated a consistent pattern of selling company shares over recent months, with no recorded purchases in the same period. According to SEC Form 4 filings, Susi executed 25 sales transactions between December 2025 and March 2026, totaling approximately $11.6 million in aggregate value. The transactions varied in size, with notable sales including a $618,975 disposition on March 6, 2026, and a $500,200 sale on March 9, 2026. Smaller but repeated sales, such as multiple transactions on March 23 and 24, 2026, ranging from $75,525 to $293,761, suggest a structured divestment strategy rather than a one-time liquidation.
The selling activity has been concentrated exclusively in IRMD, with no diversification into other securities. The absence of any buy transactions in the dataset reinforces a clear directional bias toward reducing his stake in the company. The most recent sales occurred in late March 2026, with two transactions on March 24 totaling $250,697.20 ($92,149.65 and $158,547.55). While the filings do not disclose the reasons behind these sales, the pattern indicates sustained and methodical selling over several months, contrasting with executives who balance sales with periodic acquisitions. The lack of buying activity may warrant further monitoring to assess whether this trend continues or stabilizes.
AI-assisted summary